Table 1 Demographics and clinical characteristics of OTSCC patients.

From: Nutritional and immune-related indicators-based Nomogram for predicting overall survival of surgical oral tongue squamous cell carcinoma

Characteristics

No. of patients (N = 169), n (%)

No. of events (N = 39), n (%)

Gender

Ā Male

93 (55)

21 (54)

Ā Female

76 (45)

18 (46)

Age (years)

Ā < 69

141 (84)

29 (74)

 ≄ 69

28 (16)

10 (26)

Drinking

Ā Yes

35 (21)

27 (69)

Ā No

134 (79)

12 (31)

Smoking

Ā Yes

70 (41)

18 (46)

Ā No

99 (59)

21 (54)

Tumor size (cm)

Ā < 4.5

152 (90)

30 (77)

 ≄ 4.5

17 (10)

9 (23)

TNM stage

Ā I–II

120 (71)

17 (44)

Ā III–IV

49 (29)

22 (56)

Treatment

Ā Surgery

121 (72)

16 (41)

Ā Surgery followed by radiotherapy/chemotherapy

48 (28)

23 (59)

CK (U/L)

Ā < 53.6

22 (13)

9 (23)

 ≄ 53.6

147 (87)

30 (77)

LDH (U/L)

Ā < 156.3

76 (45)

14 (36)

 ≄ 156.3

93 (55)

25 (64)

ALP (U/L)

Ā < 127

150 (89)

33 (85)

 ≄ 127

19 (11)

6 (15)

AST/ALT

Ā < 0.96

90 (53)

18 (46)

 ≄ 0.96

79 (47)

21 (54)

TP (g/L)

Ā < 73.8

120 (71)

25 (64)

 ≄ 73.8

49 (29)

14 (36)

ALB (g/L)

Ā < 47.4

150 (89)

31 (79)

 ≄ 47.4

19 (11)

8 (21)

A/G

Ā < 1.7

108 (64)

20 (51)

 ≄ 1.7

61 (36)

19 (49)

UA (umol/L)

Ā < 261

31 (18)

11 (28)

 ≄ 261

138 (82)

28 (72)

CHE (U/L)

Ā < 6027

19 (11)

8 (21)

 ≄ 6027

150 (89)

31 (79)

IgG (g/L)

Ā < 11.89

74 (44)

21 (54)

 ≄ 11.89

95 (56)

18 (46)

IgA (g/L)

Ā < 1.14

17 (10)

7 (18)

 ≄ 1.14

152 (90)

32 (82)

IgM (g/L)

Ā < 1.09

77 (46)

20 (51)

 ≄ 1.09

92 (54)

19 (49)

C3 (g/L)

Ā < 1.05

86 (51)

16 (41)

 ≄ 1.05

83 (49)

23 (59)

C4 (g/L)

Ā < 0.22

56 (33)

11 (28)

 ≄ 0.22

113 (67)

28 (72)

BF (g/L)

 < 0.27

37 (22)

15 (38)

 ≄ 0.27

132 (78)

24 (62)

CRP (mg/L)

 < 3.78

143 (85)

30 (77)

 ≄ 3.78

26 (15)

9 (23)

WBC (× 109/L)

 < 5.38

45 (27)

14 (36)

 ≄ 5.38

124 (73)

25 (64)

RBC (109/L)

 < 3.91

17 (10)

8 (21)

 ≄ 3.91

152 (90)

31 (79)

HGB (g/L)

 < 130.1

62 (37)

17 (44)

 ≄ 130.1

107 (63)

22 (56)

PLT (109/L)

 < 196

52 (31)

17 (44)

 ≄ 196

117 (69)

22 (56)

PLR

 < 177.74

146 (86)

31 (79)

 ≄ 177.74

23 (14)

8 (21)

NLR

 < 2.96

132 (78)

26 (67)

 ≄ 2.96

37(22)

13(33)

LMR

 < 2.5

22 (13)

9 (23)

 ≄ 2.5

147 (87)

30 (77)

BMI

 < 21.46

88 (52)

26 (67)

 ≄ 21.46

81 (48)

13 (33)

  1. TNM, tumor/node/metastasis; OTSCC, oral tongue squamous cell carcinoma; CK, creatine kinase; LDH, lactic dehydrogenase; ALP, alkaline phosphatase; AST/ALT, aspartate aminotransferase/ alanine aminotransferase; TP, total protein; ALB, albumin; A/G, Albumin/Globulin; UA, uric acid; CHE, cholinesterase; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; C3, Complement 3; C4, Complement 4; BF, B factor; CRP, C-reactive protein; WBC, white blood cell count; RBC, red blood cell count; HGB, hemoglobin; PLT, platelet; PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; LMR, Lymphocyte-to-monocyte ratio and BMI, Body Mass Index.